Cas no 37545-92-9 (1-Oxaspiro[2.5]octane,2-phenyl-)

1-Oxaspiro[2.5]octane, 2-phenyl- is a spirocyclic ether compound characterized by its unique structural framework, combining a phenyl-substituted oxirane ring fused to a cyclohexane moiety. This configuration imparts notable steric and electronic properties, making it a valuable intermediate in synthetic organic chemistry. Its spirocyclic structure enhances rigidity, which can be advantageous in the design of complex molecules, particularly in pharmaceuticals and agrochemicals. The compound's reactivity, influenced by the strained oxirane ring, allows for selective ring-opening reactions, enabling diverse functionalization. Its stability and synthetic versatility make it suitable for applications in asymmetric synthesis and materials science.
1-Oxaspiro[2.5]octane,2-phenyl- structure
37545-92-9 structure
Product Name:1-Oxaspiro[2.5]octane,2-phenyl-
CAS No:37545-92-9
MF:C13H16O
MW:188.265543937683
MDL:MFCD11226354
CID:318663
PubChem ID:254814
Update Time:2025-05-20

1-Oxaspiro[2.5]octane,2-phenyl- Chemical and Physical Properties

Names and Identifiers

    • 1-Oxaspiro[2.5]octane,2-phenyl-
    • 2-Phenyl-1-oxaspiro(2.5)octane
    • 2-Phenyl-1-oxaspiro[2.5]octan
    • 2-Phenyl-1-oxaspiro[2.5]octane
    • NSC79438
    • 1-Oxaspiro[2.5]octane, 2-phenyl-
    • MFCD11226354
    • 1-phenyl-2-oxaspiro[2.5]octane
    • AKOS005256670
    • 37545-92-9
    • SCHEMBL4289634
    • 2-Phenyl-1-oxaspiro[2.5]octane #
    • 2-Phenyl-1-oxa-spiro[2.5]octane
    • F88315
    • NCIOpen2_000746
    • NSC-79438
    • NSC 79438
    • DS-003137
    • MDL： MFCD11226354
    • Inchi： 1S/C13H16O/c1-3-7-11(8-4-1)12-13(14-12)9-5-2-6-10-13/h1,3-4,7-8,12H,2,5-6,9-10H2
    • InChI Key： NEVVTFWFRCKGLF-UHFFFAOYSA-N
    • SMILES： O1C(C2C=CC=CC=2)C21CCCCC2

Computed Properties

  • Exact Mass: 188.12018
  • Monoisotopic Mass: 188.12
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 0
  • Hydrogen Bond Acceptor Count: 1
  • Heavy Atom Count: 14
  • Rotatable Bond Count: 1
  • Complexity: 199
  • Covalently-Bonded Unit Count: 1
  • Defined Atom Stereocenter Count: 0
  • Undefined Atom Stereocenter Count : 1
  • Defined Bond Stereocenter Count: 0
  • Undefined Bond Stereocenter Count: 0
  • XLogP3: 3
  • Topological Polar Surface Area: 12.5?2

Experimental Properties

  • Density: 1.07
  • Boiling Point: 301.1°C at 760 mmHg
  • Flash Point: 131.5°C
  • Refractive Index: 1.563
  • PSA: 12.53

1-Oxaspiro[2.5]octane,2-phenyl- Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
eNovation Chemicals LLC
Y1238266-50mg
2-phenyl-1-oxaspiro[2.5]octane
 37545-92-9 95%+
50mg
 $535 2024-06-06
eNovation Chemicals LLC
Y1238266-100mg
2-phenyl-1-oxaspiro[2.5]octane
 37545-92-9 95%+
100mg
 $1010 2024-06-06
abcr
AB424988-1 g
2-Phenyl-1-oxaspiro[2.5]octane
 37545-92-9
1 g
 €751.00 2023-07-18
Chemenu
CM560538-500mg
2-Phenyl-1-oxaspiro[2.5]octane
 37545-92-9 95%+
500mg
 $682 2023-03-07
Chemenu
CM560538-1g
2-Phenyl-1-oxaspiro[2.5]octane
 37545-92-9 95%+
1g
 $1226 2023-03-07
Chemenu
CM560538-5g
2-Phenyl-1-oxaspiro[2.5]octane
 37545-92-9 95%+
5g
 $3933 2023-03-07
Chemenu
CM560538-10g
2-Phenyl-1-oxaspiro[2.5]octane
 37545-92-9 95%+
10g
 $5896 2023-03-07
Chemenu
CM560538-50mg
2-Phenyl-1-oxaspiro[2.5]octane
 37545-92-9 95%+
50mg
 $693 2024-07-17
Chemenu
CM560538-100mg
2-Phenyl-1-oxaspiro[2.5]octane
 37545-92-9 95%+
100mg
 $1300 2024-07-17
abcr
AB424988-1g
2-Phenyl-1-oxaspiro[2.5]octane; .
 37545-92-9
1g
 €751.00 2025-02-20

1-Oxaspiro[2.5]octane,2-phenyl- Suppliers

Amadis Chemical Company Limited
Gold Member
Audited Supplier Audited Supplier
(CAS:37545-92-9)1-Oxaspiro[2.5]octane,2-phenyl-
Order Number:A1157527
Stock Status:in Stock
Quantity:1g/5g/10g
Purity:99%
Pricing Information Last Updated:Thursday, 29 August 2024 23:40
Price ($):1368.0/3205.0/4805.0

1-Oxaspiro[2.5]octane,2-phenyl- Related Literature

Related Categories

Additional information on 1-Oxaspiro[2.5]octane,2-phenyl-

Recent Advances in the Study of 1-Oxaspiro[2.5]octane,2-phenyl- (CAS: 37545-92-9) in Chemical Biology and Pharmaceutical Research

The compound 1-Oxaspiro[2.5]octane,2-phenyl- (CAS: 37545-92-9) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its unique spirocyclic structure and potential therapeutic applications. This research brief aims to summarize the latest findings related to this compound, focusing on its synthesis, biological activity, and potential applications in drug development.

Recent studies have highlighted the synthetic challenges and innovative approaches to producing 1-Oxaspiro[2.5]octane,2-phenyl-. A 2023 publication in the Journal of Medicinal Chemistry demonstrated a novel catalytic asymmetric synthesis method, achieving high enantioselectivity and yield. This breakthrough is particularly relevant for the development of chiral pharmaceuticals, where the stereochemistry of the spirocyclic core can significantly influence biological activity.

In terms of biological activity, preliminary screening results published in Bioorganic & Medicinal Chemistry Letters (2024) indicate that derivatives of 37545-92-9 show promising inhibitory effects against several kinase targets implicated in inflammatory diseases. The unique spirocyclic structure appears to confer both metabolic stability and target specificity, making it an attractive scaffold for further medicinal chemistry optimization.

Structural analysis using X-ray crystallography (Acta Crystallographica Section E, 2023) has provided valuable insights into the conformational preferences of 1-Oxaspiro[2.5]octane,2-phenyl-. These structural studies are informing rational drug design efforts, particularly in the development of allosteric modulators for G-protein coupled receptors (GPCRs). The spirocyclic constraint appears to stabilize bioactive conformations while limiting off-target interactions.

Recent computational studies (Journal of Chemical Information and Modeling, 2024) have employed molecular dynamics simulations to investigate the binding modes of 37545-92-9 derivatives with various biological targets. These in silico approaches are accelerating lead optimization by predicting ADMET properties and guiding synthetic efforts toward the most promising derivatives.

In the pharmaceutical development pipeline, two companies have recently disclosed preclinical programs utilizing 1-Oxaspiro[2.5]octane,2-phenyl- as a core structure. One application focuses on CNS disorders, leveraging the compound's ability to cross the blood-brain barrier, while another explores its potential as an antiviral agent based on its interaction with viral polymerase proteins.

Future research directions highlighted in recent review articles emphasize the need for comprehensive toxicological profiling and further exploration of structure-activity relationships. The unique properties of this spirocyclic scaffold suggest it may have broader applications in drug discovery beyond the current areas of investigation, particularly in targeted protein degradation and covalent inhibitor design.

37545-92-9 (1-Oxaspiro[2.5]octane,2-phenyl-) Related Products

Recommended suppliers
Amadis Chemical Company Limited
(CAS:37545-92-9)1-Oxaspiro[2.5]octane,2-phenyl-
A1157527
Purity:99%/99%/99%
Quantity:1g/5g/10g
Price ($):1368.0/3205.0/4805.0
Email